(Q34386886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

meta-analysis

0 references

title

Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

major depressive disorder

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

T Kishi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

H Y Meltzer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Y Matsuda

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

21 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

published in

Psychological Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

2255-2269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain--a post hoc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

5-HT(1A) receptor function in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

The Effect of Gepirone‐ER in the Treatment of Sexual Dysfunction in Depressed Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Gepirone-ER Treatment of Hypoactive Sexual Desire Disorder (HSDD) Associated with Depression in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Zalospirone in major depression: a placebo-controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

The effects of azapirones on serotonin1A neurons of the dorsal raphe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Transcriptional regulation at a HTR1A polymorphism associated with mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Molecular genetics of bipolar disorder and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

Beyond the monoamine hypothesis: mechanisms, molecules and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

Serotonin as a developmental signal

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

Buspirone and imipramine for the treatment of major depression in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

How meta-analysis increases statistical power

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

Gepirone in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

Sexual problems in healthy and depressed persons

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713002857

7 January 2021

10.1017/S0033291713002857

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262766%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference